Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes.
Woo
J
J
Transplant Division, University of Pittsburgh, PA 15232.
Zeevi
A
A
Yao
G Z
GZ
Strednak
J
J
Todo
S
S
Thomson
A W
AW
D015704:CD4 Antigens / Q000032:analysis*; D016827:CD8 Antigens / Q000032:analysis*; D002478:Cells, Cultured; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007519:Isoantigens / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D016853:Muromonab-CD3; D009173:Mycophenolic Acid / Q000494:pharmacology*; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D012263:Ribonucleosides / Q000494:pharmacology*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D015704:CD4 Antigens; D016827:CD8 Antigens; D007166:Immunosuppressive Agents; D007519:Isoantigens; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D012263:Ribonucleosides; C010052:mizoribine; D009173:Mycophenolic Acid; D013755:Tetradecanoylphorbol Acetate; D016559:Tacrolimus